Dear Shareholders and readers
In a changing world that at the time of writing is finding its way out of the largest pandemic in modern times, Diamyd Medical is standing strong. We have built an organization that is less dependent on external help to conduct the work around clinical trials, regulatory strategy, and analysis of data. We are establishing our proprietary manufacturing to ensure long-term access to the active component of our therapeutic diabetes vaccine Diamyd® when it is time for commercialization....